MNOV
MediciNovaCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
MNOV vs peer average
62/100
MNOV vs. peer average (C vs. D)
Grade spread
B 1 · C 4 · D 3 · F 3
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
ATHE is the first available peer comparator.
Alterity is a similarly micro-cap clinical-stage neurology biotech where valuation is driven more by trial milestones and financing capacity than current revenue, making it a reasonably direct event-volatility peer.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
MNOV
MediciNova
ATHE
Alterity Therapeutics
Grade
C
D
Momentum
85
13
Value
41
49
Sentiment
57
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Defensive
Grade position vs ATHE
MNOV / ATHE
Grade Position
In line
MNOV vs. peer average (C vs. D)
62/100
Momentum
85
MNOVValue
41
ATHESentiment
57
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs MNOV
ATHE is the first peer returned for this comparison set.